Bryan C. Hanson

Bryan C. Hanson (chief executive) discloses dealings in 4 companies, chiefly Zimmer Biomet Holdings, Inc., Medtronic plc and Solventum Corp. Over a trading history stretching from 8 January 2016 to 1 September 2026, the count stands at 54 filings.

In open-market terms, that means 9 purchases worth €2.8M on one side and 10 sales worth €8.8M on the other. On balance, insiders were net sellers of €6.0M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 18 share grants and 17 option exercises.

Half of the purchases are above €52k and half below. 3 out of 9 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The latest filing, published on 3 September 2026, reports an option exercise in Solventum Corp. The latest purchase dates back some time: it was published 2,351 days ago, on 13 May 2020. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.